Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research In...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025003871 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832573051895545856 |
---|---|
author | Chenggang Lei Di Liu Qian Zhou Shengwei Ma Haiyun Qian |
author_facet | Chenggang Lei Di Liu Qian Zhou Shengwei Ma Haiyun Qian |
author_sort | Chenggang Lei |
collection | DOAJ |
description | This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found phrases that make some passages in the article difficult to parse. The authors were requested to explain the use of these passages of text but were unable to do so. The Editor has lost confidence in the findings of the article and has determined that it should be retracted.The authors have not responded to the retraction notice. |
format | Article |
id | doaj-art-06516b1b4d9044799af364a1118cdb9e |
institution | Kabale University |
issn | 2405-8440 |
language | English |
publishDate | 2025-01-01 |
publisher | Elsevier |
record_format | Article |
series | Heliyon |
spelling | doaj-art-06516b1b4d9044799af364a1118cdb9e2025-02-02T05:28:46ZengElsevierHeliyon2405-84402025-01-01112e42007Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]Chenggang Lei0Di Liu1Qian Zhou2Shengwei Ma3Haiyun Qian4Department of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaCorresponding author.; Department of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaThis article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found phrases that make some passages in the article difficult to parse. The authors were requested to explain the use of these passages of text but were unable to do so. The Editor has lost confidence in the findings of the article and has determined that it should be retracted.The authors have not responded to the retraction notice.http://www.sciencedirect.com/science/article/pii/S2405844025003871 |
spellingShingle | Chenggang Lei Di Liu Qian Zhou Shengwei Ma Haiyun Qian Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] Heliyon |
title | Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] |
title_full | Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] |
title_fullStr | Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] |
title_full_unstemmed | Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] |
title_short | Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580] |
title_sort | retraction notice to engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework a promising drug delivery nanocarrier on lung cancer cells heliyon 10 2024 e36580 |
url | http://www.sciencedirect.com/science/article/pii/S2405844025003871 |
work_keys_str_mv | AT chengganglei retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580 AT diliu retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580 AT qianzhou retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580 AT shengweima retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580 AT haiyunqian retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580 |